Literature DB >> 15558017

Silencing of human Int-6 impairs mitosis progression and inhibits cyclin B-Cdk1 activation.

Christelle Morris1, Pierre Jalinot.   

Abstract

The Int-6 protein has been originally identified as the product of a mouse gene being a frequent integration site of the mouse mammary tumour virus. Here, we show that reducing Int-6 expression by RNA interference in HeLa cells markedly alters mitosis progression. Defects in spindle formation, chromosome segregation and cytokinesis were observed. These abnormalities of mitosis completion are correlated with an inhibition of cyclin B-Cdk1 kinase activity, due to a prolonged inhibitory phosphorylated state of Cdk1. In line with this observation, the Wee1 tyrosine kinase that negatively controls Cdk1 was less efficiently inactivated during G2 in Int-6-depleted cells. These findings support the notion that the oncogenic properties associated with alteration of Int-6 originate from chromosomal instability.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15558017     DOI: 10.1038/sj.onc.1208268

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  INT6 interacts with MIF4GD/SLIP1 and is necessary for efficient histone mRNA translation.

Authors:  Julia Neusiedler; Vincent Mocquet; Taran Limousin; Theophile Ohlmann; Christelle Morris; Pierre Jalinot
Journal:  RNA       Date:  2012-04-24       Impact factor: 4.942

2.  Phosphorylation of eIF4GII and 4E-BP1 in response to nocodazole treatment: a reappraisal of translation initiation during mitosis.

Authors:  Mark J Coldwell; Joanne L Cowan; Markete Vlasak; Abbie Mead; Mark Willett; Lisa S Perry; Simon J Morley
Journal:  Cell Cycle       Date:  2013-10-01       Impact factor: 4.534

3.  The human T-lymphotropic virus type 1 tax protein inhibits nonsense-mediated mRNA decay by interacting with INT6/EIF3E and UPF1.

Authors:  Vincent Mocquet; Julia Neusiedler; Francesca Rende; David Cluet; Jean-Philippe Robin; Jean-Michel Terme; Madeleine Duc Dodon; Jürgen Wittmann; Christelle Morris; Hervé Le Hir; Vincenzo Ciminale; Pierre Jalinot
Journal:  J Virol       Date:  2012-05-02       Impact factor: 5.103

4.  Int6 and Moe1 interact with Cdc48 to regulate ERAD and proper chromosome segregation.

Authors:  Joel H Otero; Jinfeng Suo; Colin Gordon; Eric C Chang
Journal:  Cell Cycle       Date:  2010-01-09       Impact factor: 4.534

5.  Expression of human eukaryotic initiation factor 3f oscillates with cell cycle in A549 cells and is essential for cell viability.

Authors:  Ana E Higareda-Mendoza; Marco A Pardo-Galván
Journal:  Cell Div       Date:  2010-05-13       Impact factor: 5.130

6.  Arabidopsis eIF3e interacts with subunits of the ribosome, Cop9 signalosome and proteasome.

Authors:  Tal Paz-Aviram; Avital Yahalom; Daniel A Chamovitz
Journal:  Plant Signal Behav       Date:  2008-06

7.  Human INT6/eIF3e is required for nonsense-mediated mRNA decay.

Authors:  Christelle Morris; Jürgen Wittmann; Hans-Martin Jäck; Pierre Jalinot
Journal:  EMBO Rep       Date:  2007-04-20       Impact factor: 8.807

8.  Genome-wide screen identifies novel machineries required for both ciliogenesis and cell cycle arrest upon serum starvation.

Authors:  Ji Hyun Kim; Soo Mi Ki; Je-Gun Joung; Eric Scott; Susanne Heynen-Genel; Pedro Aza-Blanc; Chang Hyuk Kwon; Joon Kim; Joseph G Gleeson; Ji Eun Lee
Journal:  Biochim Biophys Acta       Date:  2016-03-28

9.  Int6 regulates both proteasomal degradation and translation initiation and is critical for proper formation of acini by human mammary epithelium.

Authors:  J Suo; S J Snider; G B Mills; C J Creighton; A C Chen; R Schiff; R E Lloyd; E C Chang
Journal:  Oncogene       Date:  2010-10-04       Impact factor: 9.867

10.  The INT6 cancer gene and MEK signaling pathways converge during zebrafish development.

Authors:  Michal Grzmil; Danny Whiting; John Maule; Corina Anastasaki; James F Amatruda; Robert N Kelsh; Chris J Norbury; E Elizabeth Patton
Journal:  PLoS One       Date:  2007-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.